Stryker Co. (NYSE:SYK) Shares Acquired by Schear Investment Advisers LLC

Schear Investment Advisers LLC increased its position in shares of Stryker Co. (NYSE:SYK) by 11.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,582 shares of the medical technology company’s stock after buying an additional 365 shares during the period. Schear Investment Advisers LLC’s holdings in Stryker were worth $1,290,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Fortress Financial Solutions LLC acquired a new stake in shares of Stryker during the fourth quarter worth approximately $272,000. Community Bank & Trust Waco Texas grew its holdings in Stryker by 14.8% during the 4th quarter. Community Bank & Trust Waco Texas now owns 1,080 shares of the medical technology company’s stock worth $389,000 after acquiring an additional 139 shares in the last quarter. Peterson Wealth Services increased its position in shares of Stryker by 0.5% in the 4th quarter. Peterson Wealth Services now owns 12,828 shares of the medical technology company’s stock worth $4,619,000 after purchasing an additional 68 shares during the last quarter. Stonebridge Financial Group LLC acquired a new stake in shares of Stryker in the 4th quarter valued at about $4,553,000. Finally, Mill Creek Capital Advisors LLC lifted its position in shares of Stryker by 22.3% during the fourth quarter. Mill Creek Capital Advisors LLC now owns 745 shares of the medical technology company’s stock worth $268,000 after purchasing an additional 136 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on SYK shares. BTIG Research upped their price objective on Stryker from $383.00 to $394.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. StockNews.com downgraded shares of Stryker from a “buy” rating to a “hold” rating in a report on Thursday, January 30th. Stifel Nicolaus raised their price target on shares of Stryker from $400.00 to $440.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Needham & Company LLC reaffirmed a “buy” rating and set a $442.00 price objective on shares of Stryker in a research report on Wednesday, January 29th. Finally, Truist Financial raised their target price on shares of Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a report on Thursday, January 30th. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $420.68.

Stryker Price Performance

NYSE SYK opened at $390.52 on Wednesday. Stryker Co. has a 12 month low of $314.93 and a 12 month high of $406.19. The firm has a market capitalization of $148.88 billion, a PE ratio of 50.33, a P/E/G ratio of 2.98 and a beta of 0.96. The company’s 50 day simple moving average is $377.28 and its 200 day simple moving average is $365.59. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, topping analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period in the prior year, the firm posted $3.46 EPS. As a group, equities research analysts forecast that Stryker Co. will post 13.49 EPS for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. The ex-dividend date is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. Stryker’s dividend payout ratio (DPR) is 43.30%.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.